-+ 0.00%
-+ 0.00%
-+ 0.00%

Anavex regains Nasdaq compliance after filing overdue quarterly reports

PUBT·09/02/2026 20:00:21
Listen to the news
Anavex regains Nasdaq compliance after filing overdue quarterly reports
  • Nasdaq confirmed Anavex regained compliance with Listing Rule 5250(c)(1) on periodic SEC filing requirements.
  • Outstanding Form 10-Qs for fiscal Q2 2026 and Q3 2026 were filed on Aug. 28, 2026.
  • Common stock will continue trading on the Nasdaq Global Select Market under ticker AVXL.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anavex Life Sciences Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609021600PRIMZONEFULLFEED9820466) on September 02, 2026, and is solely responsible for the information contained therein.